Logo-jpd
Editorial

1. An update on sclerostin and kidney
Hamid Nasri*
J Parathyr Dis. 2016;4(1): 1-2.
Article
PDF
XML
Cited By:
Epidemiology and Prevention

2. Fibroblast growth factor 23 and cardiovascular disease in chronic kidney disease; new trends
Azar Baradaran*
J Parathyr Dis. 2018;6(1): 1-2. doi: 10.15171/jpd.2018.01
Article
PDF
XML
Cited By:
0
Original

3. Correlation of fibroblast growth factor 23 in chronic kidney disease patients with biochemical parameters and outcomes
Anand Yuvaraj, Georgi Abraham*, Madhusudan Vijayan, Jayaraju Jayapal, Saranya Kulanthaipandian, Sanjeev Nair
J Parathyr Dis. 2016;4(1): 7-10.
Article
PDF
XML
Cited By:
Editorial

4. FGF 23 and cardiovascular outcome in chronic kidney disease
 
Farrokhlagha Ahmadi*
J Parathyr Dis. 2016;4(2): 34-35.
Article
PDF
XML
Cited By:
Original

5. Levels of parathyroid hormone and fibroblast growth factor 23 in various stages of pediatric patients with chronic kidney disease
Mohsen Akhavan Sepahi ORCID, Mohammad Reza Razavi* ORCID, Mohammad Heidari, Mohammad Reza Haeri, Abolfazl Mohammadbeigi
J Parathyr Dis. 2020;8: e03 | Published on: 2019 Aug 18.
Article
PDF
XML
Cited By:
Mini-Review

6. Relationship between Klotho and parathormone
Azar Baradaran* ORCID
J Parathyr Dis. 2023;11: e11230 | Published on: 2023 Aug 14. doi: 10.34172/jpd.2023.11230
Article
PDF
XML
Cited By: